These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4645697)

  • 1. [Arrhythmia prophylaxis with procanamide: inadequate dosage?].
    Collste P; Karlsson E; Norlander B; Sievers J; Sjöqvist F
    Lakartidningen; 1972 Jun; 69():Suppl 2:47-50. PubMed ID: 4645697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
    Bliddal J
    Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
    Henningsen P; Laursen HB; Christiansen BD; Moller J
    Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
    [No Abstract]   [Full Text] [Related]  

  • 4. Experiences on a sustained-release procainamide preparation.
    Ruosteenoja R; Torsti P; Sothmann A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical use of procainamide.
    Miller RR; Greenblatt DJ
    Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
    [No Abstract]   [Full Text] [Related]  

  • 6. Procainamide acetylation and disposition in dialysis patients.
    Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
    Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical aspects and treatment of paroxysmal forms of cardiac rhythm disorders].
    Vasilenko VKh; Golochevskaĭa VS; Fomina IG
    Ter Arkh; 1973 Dec; 45(12):46-55. PubMed ID: 4779666
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of a new sustained release procainamide preparation: evaluation with 24-hour Holter monitoring.
    Garcia JR; Godley ML; Freedman RJ
    J La State Med Soc; 1982; 134(1):8-9. PubMed ID: 7086265
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of plasma levels in evaluation of procainamide dosage.
    Shaw TR; Kumana CR; Royds RB; Padgham CM; Hamer J
    Br Heart J; 1974 Mar; 36(3):265-70. PubMed ID: 4132893
    [No Abstract]   [Full Text] [Related]  

  • 11. [Procain amide and phenytoin as anti-arrhythmia agents, some dosage principles].
    Karlsson E
    Tidsskr Nor Laegeforen; 1974 Jun; 94(18):1198-200. PubMed ID: 4839996
    [No Abstract]   [Full Text] [Related]  

  • 12. Intermittent intravenous procaine amide to treat ventricular arrhythmias. Correlation of plasma concentration with effect on arrhythmia, electrocardiogram, and blood pressure.
    Giardina EG; Heissenbuttel RH; Bigger JT
    Ann Intern Med; 1973 Feb; 78(2):183-93. PubMed ID: 4683748
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentration of procainamide and prevalence of exertional arrhythmias.
    Gey GO; Levy RH; Fisher L; Pettet G; Bruce RA
    Ann Intern Med; 1974 Jun; 80(6):718-22. PubMed ID: 4832159
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias.
    Michelson EL; McGeehin FC; Levin BK
    Angiology; 1988 Jul; 39(7 Pt 2):647-54. PubMed ID: 3044199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of blood tests in procaine amide use (apropos of 188 tests in 36 patients)].
    Chiche P; Benaim R; Lellouch A; Godard JP
    Arch Mal Coeur Vaiss; 1972 Jul; 65(7):797-803. PubMed ID: 4633517
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.
    Levy RH; Gey GO; Bruce RA
    J Pharm Sci; 1974 Dec; 63(12):1958-9. PubMed ID: 4449032
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative evaluation of intravenous phenytoin, procainamide and practolol in the acute treatment of ventricular arrhythmias.
    Karlsson E; Kinman A; Sonnhag C
    Eur J Clin Pharmacol; 1977; 11(1):1-6. PubMed ID: 832652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
    Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
    Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
    [No Abstract]   [Full Text] [Related]  

  • 19. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
    Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R
    Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of the anginose symptom complex and arrhythmia with stenocardin].
    Küchler I
    Med Welt; 1968 Mar; 12():771-3. PubMed ID: 5753328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.